Prescribing overview
Veterinarian-directed extra-label anticonvulsant, muscle relaxant or anesthetic adjunct; oral feline use carries a documented severe liver-injury risk.
Primary veterinary studies support anesthetic adjunct use in dogs and ponies.
Feline oral hepatotoxicity is a distinct route-specific concern.
Key prescribing checks
- Oral feline administration has been associated with fulminant hepatic failure.
- This finding must not be treated as a blanket prohibition on clinician-directed emergency injectable feline use.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Dogs and horses
Extra-label relative to human Valium labelAnesthetic co-induction with ketamine
Requires a professional anesthesia plan.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Enhances GABA-mediated inhibitory neurotransmission.
Absorption, distribution, metabolism and elimination
No veterinary quantitative pharmacokinetic regimen verified; formulation and species matter.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Valium
Exact veterinary label scope where available; human products identify ingredients and human warnings, not veterinary approval.
Contraindications · when not to use
- Human-label contraindications are not automatically animal contraindications.
Precautions & monitoring
- Cats: serious idiosyncratic hepatic injury has been reported with oral use.
- Sedation, ataxia and paradoxical behavior require patient-specific review.
Human approval does not establish approval or safety in any animal species. Formulation, route and patient context require veterinarian review.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Sedation, incoordination and respiratory depression with other depressants; severe hepatic injury reported in cats given oral treatment.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
No dosing table is supplied. All administration requires a species-, product- and route-specific veterinary plan; human package directions are not veterinary instructions.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
Valium
Exact veterinary label scope where available; human products identify ingredients and human warnings, not veterinary approval.
- Human labeling warns of profound sedation and respiratory depression with opioids; veterinary coadministration requires clinician interpretation and monitoring.
Monitoring
Sedation and breathing
Coordination and behavior
Liver assessment if feline oral treatment is contemplated
Client counseling
Do not use human directions for animals.
Report feline appetite loss, vomiting, lethargy or jaundice promptly.
Do not abruptly stop ongoing treatment without the prescribing veterinarian.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow exact product storage and controlled-drug requirements; secure away from animals.
Brands, formulations & ingredient identity
Active ingredients
Diazepam
Other searchable names: Valium · diazepam
Valium reviewed here is a human oral tablet product, available in 2, 5 and 10 mg strengths.
Oral tablets, injection and rectal products are distinct formulations and are not interchangeable instructions.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Valium
- Formulation
- Human diazepam oral tablets (2, 5 or 10 mg)
- Label / product scope
- Human product
Human label only; no veterinary species approval conferred.
Product label / source ↗References & review status
Clinical reference updated October 26, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
